Skip to main content

Table 2 Preoperative clinicopathological data of all patients enrolled

From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study

Clinicopathologic data

PCG(N = 68)

M (IQR) orN (%)

CG (N = 41)

M (IQR) orN (%)

P

Admission waiting (day)

4.5 (2–7.75)

8.0 (2–20)

0.006*

Operation waiting (day)

3 (2–5)

7 (5–9)

0.000*

Comorbidity

  

0.144

 Yes

46

22

 

 No

22

19

 

Tumor marker

  

0.298

 CEA

2.12

1.85

0.771

 AFP

2.85

3.01

0.883

 CA199

9.70

9.63

0.863

 CA724

2.03

2.13

 

Clinical TNM stage

  

0.112

 I

17

4

 

 II

18

14

 

 III

30

23

 

 IV

3

0

 

Hemoglobin

138.50 (119.25–148.75)

143.00 (119.50–151.00)

0.726

Chest CT scan

  

0.000*

 Yes

24

30

 

 No

44

11

 
  1. PCG Pre-COVID-19 group, CG COVID-19 group, CT Computed tomography; c, N Number
  2. * P < 0.05, statistically different